MOTS-c — a year of dosing, metabolic labs, and what I actually think is happening

M
Joined 2026
32 posts
motsc_opsMember
2/11/2026 · 4873 views

Year of MOTS-c in the books. Posting because the writeups on this compound are mostly 'felt great' with no numbers, and the skeptic takes are mostly 'no human data' without engaging with what the human data that exists actually says.

Me: 45F, T2D family hx but personally pre-metabolic-syndrome-y (HbA1c 5.6, fasting glucose 98, HOMA-IR 2.1 at baseline), BMI 27, lifting 3x/week + Zone 2 3x/week. Nothing else changed during the trial year.

Dose: 10 mg SubQ once weekly, Monday AM. Ran 8 weeks on / 4 weeks off cycles, four cycles total. Picked the weekly dose based on the Lee 2015 paper and the subsequent pharmacokinetic work.

Labs, cycle-by-cycle (baseline -> end):

  • HbA1c: 5.6 -> 5.3 -> 5.3 -> 5.2 -> 5.2
  • Fasting glucose: 98 -> 92 -> 90 -> 88 -> 89
  • Fasting insulin: 7.4 -> 6.1 -> 5.8 -> 5.5 -> 5.7
  • HOMA-IR: 2.1 -> 1.4 -> 1.3 -> 1.2 -> 1.3
  • ApoB: 88 -> 85 -> 86 -> 84 -> 82
  • hs-CRP: 1.8 -> 1.2 -> 1.0 -> 1.1 -> 1.0
  • Body fat (DEXA): 31% -> 29% -> 28% -> 28% -> 27%

Caveats (obligatory):

  • Training and diet were stable but not measured to the gram. A 5-10% improvement in diet adherence over a year on its own could move many of these markers.
  • I also lost ~8 lb over the year. Weight loss alone moves HOMA-IR and insulin sensitivity.
  • MOTS-c has been a darling of the longevity community for about 3 years without a lot of human RCT support. My data is consistent with 'it's working' and consistent with 'I got healthier and it took credit.'

Mechanism, as I understand it: MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA mitochondrial gene. It upregulates AMPK, improves insulin sensitivity in muscle, and seems to have anti-inflammatory effects. Read the Lee lab papers if you're curious.

What I'll keep: yes. The ratio of injection burden (1/wk) to plausible benefit (real, even if I can't isolate it) is the best in the longevity class IMO.

Happy to answer questions, will not discuss sources.

15 Replies

H
Joined 2026
33 posts
2/12/2026

These are exactly the labs I'd want to see. HOMA-IR from 2.1 to 1.3 in a year is real regardless of what drove it. Fasting insulin dropping ~25% is meaningful.

M
Joined 2026
32 posts
motsc_opsMember
2/12/2026

@panel_maxer yes — labs drawn 5 days after the last dose of each 8-week block, always a Friday AM after 12h fast. Wanted consistency over optimizing for peak effect.

P
Joined 2026
50 posts
2/13/2026

Good writeup. Question: did you time bloodwork to a consistent point in the dosing cycle? (e.g., always week 6 of an 8-week on block, always 5 days post-dose, etc.) Because AMPK activation is transient and the exact timing matters for interpreting fasting insulin.

N
Joined 2026
34 posts
2/13/2026

Published human MOTS-c data is thin. The in vitro and rodent work is cleaner. Your ApoB drop (88 -> 82) is consistent with modest weight loss plus improved insulin sensitivity; it's not MOTS-c-specific signature. The HOMA-IR trajectory is the most interesting piece.

A
Joined 2026
31 posts
2/13/2026

ApoB move is in the noise, I wouldn't hang anything on it. HOMA-IR is the real signal. That's a substantial improvement that would be clinically meaningful if repeatable.

S
Joined 2026
115 posts
2/14/2026

MOTS-c as a signaling peptide is one of the more interesting stories in mitochondrial biology. The therapeutic translation is unproven. Your data doesn't prove it either, but it's a useful data point. Stack of similar writeups is how the pattern becomes real.

D
Joined 2026
45 posts
2/15/2026

3% body fat off via DEXA across a year at stable weight (or ~8 lb loss with presumably some lean mass retention) is a legit body recomposition. That alone explains most of the metabolic markers.

M
Joined 2026
32 posts
motsc_opsMember
2/15/2026

@dexa_devotee agreed. I want to be careful not to attribute to MOTS-c what's probably belongs to 'I got leaner and my training was consistent.' That's why I flagged it.

E
Joined 2026
36 posts
2/18/2026

Running MOTS-c alongside Epithalon. MOTS-c feels like the clearer metabolic lever, Epi feels like the clearer sleep lever. If I could keep only one, MOTS-c.

D
Joined 2025
119 posts
dr_doubtRegular
2/18/2026

The 1/wk dosing is the right framing for this compound. People running it daily are optimizing a variable they don't have good evidence matters. Pulsatile AMPK activation, not sustained.

P
Joined 2026
16 posts
2/19/2026

The honest uncertainty in this post ('consistent with MOTS-c working and consistent with me getting healthier and it took credit') is what I want from longevity writeups. Not certainty — calibrated uncertainty.

H
Joined 2026
22 posts
2/22/2026

HOMA-IR 2.1 to 1.3 is the number I'm going to think about all week. That's a real metabolic shift.

M
Joined 2026
31 posts
2/23/2026

Curious if you'd have gotten the same markers from Zone 2 + lifting + 8 lb loss without MOTS-c. Genuine question not a jab.

M
Joined 2026
32 posts
motsc_opsMember
2/23/2026

@macrosguru honestly, maybe. HOMA-IR moves a lot with body comp. I think MOTS-c helped accelerate the fat loss. Can't prove it.

C
Joined 2026
71 posts
24d ago

Writeup is good but the correct reference paper to cite for MOTS-c mechanism is Lee et al 2015 Cell Metabolism. Everyone on here handwaves 'AMPK.' Cite the paper.

Sign in to reply.